Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Research Article Volume 6 Issue 1

Covid 19 Situation Update in the Pediatric Population at EHU Oran

Djamila-Djahida Batouche1-3*, Sid Ahmed Bakri1, Houcine Saddok1,2, Dalila Ali-Amar2, Radia Dali-Youcef2,4, Douniazed Badsi2, Soulef-Amel Saadi2,5, Nadia-Faiza Benatta2 and Chafika Manouni2

1Pediatric and Neonatal Anesthesia - Intensive Care Unit EHU Oran, Algeria

2Faculty of Medicine, Oran 1, Algeria

3LERMER Research Laboratory, University Oran 1, Algeria

4Bacteriology Service, EHU Oran, Algeria

5Department of Biochemistry, EHU Oran, Algeria

*Corresponding Author: Djamila-Djahida Batouche, Pediatric and Neonatal Anesthesia - Intensive Care Unit EHU Oran, Algeria.

Received: November 29, 2021; Published: December 20, 2021

Abstract

Today we have enough scientific publications showing that the majority of children infected with SARS-CoV-2 have a very favorable outcome. At present, morbidity in children remainslow and deathis an extremely rare event. The purpose of this article is to describe the pediatrics pecificities of covid 19 viral infection in children admitted to EHU Oran. Materials-methods:Were corded over a 10-month period (March 1 to December 30, 2020) the data using a pre-established survey sheet. We are included all children under the age of 17. For each patient, we are studied the socio-demographic parameters, the clinical signs at the consultation, the results of the PCR and the child's fate. Result: 302 children admitted with a mean age of 8.04 ± 0.2 years were the subject of the study The children were most often asymptomatic and very few children had presented a mildform (digestive pain, fever, cough, rhinorrhea), all were hospitalized with their parents, in different hospital service welcoming covid pathology at EHUO. The PCR was positive in 40% of the children. A multisystemic inflammatory syndrome in post covid 19 was noted in three patient. Conclusion:Children represent only a small percentage of cases of acute SARS-CoV-2 infection and are generally asymptomatic, or have mild to moderate symptoms.

 

Keywords: Child; SARS-CoV-2; Mild Symptomatology; PIMS; Favorable Prognosis

References

  1. Wu Z and McGoogan JM. “Characteristics and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention”. Journal of the American Medical Association 323 (2020): 129-142.
  2. Meng-Yao Zhou and Xiao-Li Xie. “From SARS to COVID-19: What we have learned about children infected with COVID-19”. International Journal of Infectious Diseases 96 (2020): 710-714.
  3. Pediatric Acute Lung Injury Consensus Conference Group. “Pediatric acute respiratory distress syndrome: consensus recommendations from the pediatric acute lung injury consensus conference”. Pediatric Critical Care Medicine 16 (2015): 428-439.
  4. “Zimmermann and Curtis”. The Pediatric Infectious Disease Journal5 (2020).
  5. Ludvigsson Jonas F. “Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults”. Acta Paediatrica 109 (2020): 1088-1095.
  6. Qiu H., et al. “Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study”. Lancet Infectious Disease6 (2020): 689-696.
  7. Yuanzhe Li., et al. “Insight into COVID-2019 for pediatricians”. Pediatric Pulmonology5‎ (2020): E1-E4.
  8. Ferdinando D’Amico., et al. “Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management”. Clinical Gastroenterology and Hepatology8 (2020): 1663-1672.
  9. Lu X., et al. “SARS-CoV-2 Infection in children”. The New England Journal of Medicine (2020).
  10. Bucher K. “Coronavirus Disease 2019 (COVID-19) in Italy”. Journal of the American Medical Association14 (2020): 1335.
  11. Ambrosioni J., et al. “Epidemiology of viral respiratory infections in a tertiary care centre in the era of molecular diagnosis, Geneva, Switzerland, 2011-2012”. Clinical Microbiology and Infection 20 (2014): 578-584.
  12. Liu W., et al. “Detection of Covid-19 in Children in Early January 2020 in Wuhan, China”. The New England Journal of Medicine 382 (2020): 1370-1371.
  13. Dong Y., et al. “Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China”. Pediatrics 6 (2020): e20200702.
  14. Leeb RT., et al. “COVID-19 Trends Among School-Aged Children - United States, March 1-September 19, 2020”. Morbidity and Mortality Weekly Report 39 (2020): 1410-1425.
  15. Swann OV., et al. “Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study”. BMJ 370 (2020): m3249.
  16. Bellino S., et al. “COVID-19 Disease Severity Risk Factors for Pediatric Patients in Italy”. Pediatrics 4 (2020).
  17. https://www.elwatan.com/edition/actualite/sidi-slimane-la-population-entre-stupeur-et-deni-apres-lannonce-du-deces-du-premier-cas-de-covid-19-enfant-dalgerie-08-04-2020
  18. https://www.algerie360.com/covid-19-deces-dun-bebe-de-11-mois-a-batna/
  19. Centers for Disease Control and Prevention, Health Alert Network (U.S.). “Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19)” (2020).
  20. McCrindle BW and Manlhiot C. “SARS-CoV-2-related Inflammatory Multisystem Syndrome in children: different or share etiology and pathophysiology as Kawasaki disease?” Journal of the American Medical Association3 (2020): 246-248.

Citation

Citation: Djamila-Djahida Batouche., et al. “Covid 19 Situation Update in the Pediatric Population at EHU Oran". Acta Scientific Medical Sciences 6.1 (2022): 185-190.

Copyright

Copyright: © 2022 Djamila-Djahida Batouche., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





Contact US